Goldman Removes Amylin (AMLN) from Conviction Buy List; Maintains Buy
Tweet Send to a Friend
Goldman Sachs removes Amylin Pharmaceuticals (Nasdaq: AMLN) from its Conviction ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
